Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03363373
Title Naxitamab for Neuroblastoma With Osteomedullary Disease
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Y-mAbs Therapeutics
Age Groups: child | senior | adult
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | CAN

No variant requirements are available.